tiprankstipranks
Arbutus Biopharma’s Promising cHBV Treatment Results
PremiumCompany AnnouncementsArbutus Biopharma’s Promising cHBV Treatment Results
2M ago
Arbutus Biopharma’s Trial Boosts Hepatitis B Treatment
Premium
Company Announcements
Arbutus Biopharma’s Trial Boosts Hepatitis B Treatment
2M ago
Arbutus Biopharma announces new data from IM-PROVE I Phase 2a trial
Premium
The Fly
Arbutus Biopharma announces new data from IM-PROVE I Phase 2a trial
2M ago
Arbutus Biopharma files $300M mixed securities shelf
PremiumThe FlyArbutus Biopharma files $300M mixed securities shelf
2M ago
Arbutus Biopharma Reports Promising Clinical Trial Results
Premium
Company Announcements
Arbutus Biopharma Reports Promising Clinical Trial Results
2M ago
Arbutus Biopharma reports Q3 EPS (10c), consensus (9c)
Premium
The Fly
Arbutus Biopharma reports Q3 EPS (10c), consensus (9c)
2M ago
Arbutus Biopharma announces abstracts highlighting imdusiran data
PremiumThe FlyArbutus Biopharma announces abstracts highlighting imdusiran data
3M ago
Arbutus Biopharma CSO Michael Sofia Announces Retirement Plans
Premium
Company Announcements
Arbutus Biopharma CSO Michael Sofia Announces Retirement Plans
3M ago
Arbutus Biopharma to Share Insights at Viral Hepatitis Conference
Premium
Company Announcements
Arbutus Biopharma to Share Insights at Viral Hepatitis Conference
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100